T-101 recalls
The FDA has published 1 recall involving T-101 since 2022. The latest was reported on 4 May 2022. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 4 May 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why t-101 is recalled
Companies
By year
All t-101 recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | T-101, Papaverine 17.65 mg/mL . Phentolamine 0.59 mg/mL . recalled | Olympia Compounding Pharmacy | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking T-101?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.